The Sydney Morning Herald spoke with InteliCare CEO and Managing Director, Jason Waller, to discuss InteliCare’s momentum on the back of the coronavirus pandemic.
On the back of the COVID-19 (coronavirus) outbreak that is happening worldwide, Stockhead took a look at the Australian medical technology companies that are well placed to benefit from the increase in medtech and telehealth demand.
The Australian Financial Review takes a look at InteliCare’s initial public offering (IPO) and why it could be one of the only companies not pausing its run.
InteliCare‘s CEO and Managing Director, Jason Waller, writes for The Australian on how innovative technology is the solution to Australia’s ageing population.
Stockhead: JP Equity Partners on the potential for new tech solutions to disrupt Australian aged care market
Stockhead sat down with Nic Brownbill, a director at investment and advisory firm JP Equity Partners to discuss how private businesses, and InteliCare specifically, will play a role in meeting the demand.
Stockhead: IPO Watch: Intelicare eyes ASX listing to drive growth for its AI-based aged care technology
Speaking with Stockhead, InteliCare CEO, Jason Waller explains why InteliCare is poised for a growth period following a successful R&D phase.
InteliCare’s CEO, Jason Waller, speaks with the Australian Financial Review about InteliCare’s potential and how the SaaS product appeals to both business-to-business and business-to-consumer.
InteliCare has been identified as a leading tech startup and invited to Microsoft Ignite the Tour in Sydney as part of the Startup program in February 2020.